» Articles » PMID: 35132962

MTOR Inhibition Prevents Angiotensin II-induced Aortic Rupture and Pseudoaneurysm but Promotes Dissection in Apoe-deficient Mice

Abstract

Aortic dissection and rupture are triggered by decreased vascular wall strength and/or increased mechanical loads. We investigated the role of mTOR signaling in aortopathy using a well-described model of angiotensin II-induced dissection, aneurysm, or rupture of the suprarenal abdominal aorta in Apoe-deficient mice. Although not widely appreciated, nonlethal hemorrhagic lesions present as pseudoaneurysms without significant dissection in this model. Angiotensin II-induced aortic tears result in free rupture, contained rupture with subadventitial hematoma (forming pseudoaneurysms), dilatation, or healing, while the media invariably thickens regardless of mural tears. Medial thickening results from smooth muscle cell hypertrophy and extracellular matrix accumulation, including matricellular proteins. Angiotensin II activates mTOR signaling in vascular wall cells, and inhibition of mTOR signaling by rapamycin prevents aortic rupture but promotes dissection. Decreased aortic rupture correlates with decreased inflammation and metalloproteinase expression, whereas extensive dissection correlates with induction of matricellular proteins that modulate adhesion of vascular cells. Thus, mTOR activation in vascular wall cells determines whether aortic tears progress to dissection or rupture. Previous mechanistic studies of aortic aneurysm and dissection by angiotensin II in Apoe-deficient mice should be reinterpreted as clinically relevant to pseudoaneurysms, and mTOR inhibition for aortic disease should be explored with caution.

Citing Articles

Hemodynamic disturbance and mTORC1 activation: Unveiling the biomechanical pathogenesis of thoracic aortic aneurysms in Marfan syndrome.

Liu M, Wang M, Liu J, Sun A, He C, Cong X J Pharm Anal. 2025; 15(2):101120.

PMID: 39989903 PMC: 11847113. DOI: 10.1016/j.jpha.2024.101120.


SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression.

Leng S, Li H, Zhang P, Dang Z, Shao B, Xue S Arterioscler Thromb Vasc Biol. 2024; 45(2):238-259.

PMID: 39633576 PMC: 11748913. DOI: 10.1161/ATVBAHA.124.321421.


Intimomedial tears of the aorta heal by smooth muscle cell-mediated fibrosis without atherosclerosis.

Hassab A, Hur D, Vallabhajosyula P, Tellides G, Assi R JCI Insight. 2024; 9(9).

PMID: 38592807 PMC: 11141924. DOI: 10.1172/jci.insight.172437.


Modifying miRs for effective reprogramming of fibroblasts to cardiomyocytes.

Wang X, Baksh S, Pratt R, Dzau V, Hodgkinson C Mol Ther Nucleic Acids. 2024; 35(2):102160.

PMID: 38495845 PMC: 10943962. DOI: 10.1016/j.omtn.2024.102160.


Minimally invasive closure of a progressive pseudoaneurysm of the ascending aorta: A case report.

Wu Y, Fan L, Liu F, Zhuang H, Wu X Front Cardiovasc Med. 2023; 10:1134196.

PMID: 37008339 PMC: 10064447. DOI: 10.3389/fcvm.2023.1134196.


References
1.
Jiang F, Jones G, Dusting G . Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice. Br J Pharmacol. 2007; 152(6):880-90. PMC: 2078223. DOI: 10.1038/sj.bjp.0707449. View

2.
Trachet B, Piersigilli A, Fraga-Silva R, Aslanidou L, Sordet-Dessimoz J, Astolfo A . Ascending Aortic Aneurysm in Angiotensin II-Infused Mice: Formation, Progression, and the Role of Focal Dissections. Arterioscler Thromb Vasc Biol. 2016; 36(4):673-81. DOI: 10.1161/ATVBAHA.116.307211. View

3.
Satoh K, Nigro P, Matoba T, ODell M, Cui Z, Shi X . Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med. 2009; 15(6):649-56. PMC: 2704983. DOI: 10.1038/nm.1958. View

4.
Kimura T, Shiraishi K, Furusho A, Ito S, Hirakata S, Nishida N . Tenascin C protects aorta from acute dissection in mice. Sci Rep. 2014; 4:4051. PMC: 3920275. DOI: 10.1038/srep04051. View

5.
Bossone E, LaBounty T, Eagle K . Acute aortic syndromes: diagnosis and management, an update. Eur Heart J. 2017; 39(9):739-749d. DOI: 10.1093/eurheartj/ehx319. View